Contributor Page
Reed Smith
Email  |  Website  |  Articles
Contact Details
Tel: +1 412 2883131
Fax: +1 412 2883063
Reed Smith Centre
225 Fifth Avenue
United States
By Brian Sutherland
Copyright holders have an exclusive right to display images and other works.
By Andrew Levad, Jason Gordon
Not since Mariah Carey claimed "I don't know her" about Jennifer Lopez has such supreme shade been thrown on public record.
By James Beck
Today's guest post is by friend of the blog Dick Dean, of Tucker Ellis.
By Andrew Levad, Jason Gordon
InfoCision, Inc., an Akron, Ohio-based company, agreed last month to pay a $250,000 civil penalty and implement recordkeeping and monitoring practices to settle Federal Trade Commission ...
By Stephen J. McConnell
When a drug or device case goes to trial, who is the most important witness? Let's straightaway eliminate the plaintiff as a possible answer to that question.
By Gerard Stegmaier, Wendell Bartnick, Kelley Chittenden
"Sensitive information" is hard to accurately define, but the Federal Trade Commission (FTC or the Commission) seemingly knows it when it sees it.
By Andrew Levad, Jason Gordon
Last month, a New York federal judge dismissed a proposed class action that alleged Dannon Company, Inc. unlawfully labelled its yogurt products as "natural" when in fact the cows that produced the milk that produced the yogurt may have eaten feed made from corn that was genetically modified or were raised using hormones or antibiotics.
By Michelle Yeary
This should not be controversial. It has been settled since Hahn v. Richter, 673 A.2d 888 (Pa. 1996) that in Pennsylvania prescription drugs are exempt from strict liability.
By James Beck
With plaintiffs desperate to find some way to continue pursuing aggravated, aggregated product liability litigation in their favorite venues after Daimler AG v. Bauman ...
By James Beck
If you're not interested in Pennsylvania product liability law at the moment, come back tomorrow.
By Kimberly Chow, Jason Gordon
Reservation Counter, LLC and its parents companies have settled Federal Trade Commission charges that they misrepresented hotel bookings and credit card charges to consumers.
By Debra McCurdy
The Trump Administration has released its fiscal year (FY) 2019 budget proposal, which includes extensive health policy provisions.
By Rachel B. Weil
With one glance at the calendar, regular readers of this blog will have been able to predict the content of these prefatory paragraphs, later to be (tenuously) tied to today's case.
By Steven Boranian
Class actions hold our interest, even though we do not see them all that often anymore in the drug and medical device space.
By Eric Alexander
We have written extensively on the travesty of the Neurontin trilogy (like here and here) and noted how the plaintiffs' efforts to fit cases based on alleged off-label promotion ...
Contributor's Topics